Establishment and characterization of MTDH knockdown by artificial microRNA interference - functions as a potential tumor suppressor in breast cancer

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 6, 2012, Pages 2813-2818

  Wang, Song ^a   Shu, Jie Zhi ^a   Cai, Yi ^a   Bao, Zheng ^a   Liang, Qing Mo ^a,b  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b THE FIRST AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Breast cancer; MicroRNA; Migration; Motility; MTDH; Proliferation

Indexed keywords

EID: 84874044706     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.6.2813     Document Type: Article

References (24)

1. Brown DM, Ruoslahti E (2004). Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell, 5, 365-74
2. Boudreau RL, Martins I, Davidson BL et al (2009). Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo. Mol Ther, 17, 169-75
3. Calin GA, Sevignani C, Dumitru CD, et al (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc NatlAcad Sci U SA, 101, 2999-3004
4. Chen D, Yoo BK, Santhekadur PK, et al (2011). Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma. Clin Cancer Res, 17, 6693-701
5. Hui AB, Bruce JP, Alajez NM, et al (2011). Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clin Cancer Res, 17, 7539-50.
6. Hu G, Chong RA, Yang Q, et al (2009). MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell, 15, 9-20.
7. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 134.
8. Jian-bo X, Hui W, Yu-long H, et al (2011). Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Med Oncol, 28, 455-62.
9. Kang DC, Su ZZ, Sarkar D, et al (2005). Cloning and characterization of HI V-1 -inducible astrocyte elevated gene-1, AEG-1. Gene, 353, 8-15.
10. Kikuno N, Shiina H, Urakami S, et al (2007). Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene, 26, 7647-55.
11. Lee SG, Su ZZ, Emdad L, et al (2008). Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene, 27, 1114-21.
12. Li C, Liu J, Lu R, et al (2011). AEG -1 overexpression: a novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers. Int J Gynecol Cancer, 21, 602-8.
13. Li J, Yang L, Song L, et al (2009). Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. Oncogene, 28, 3188-96.
14. Li J, Zhang N, Song LB, et al (2008). Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res, 14, 3319-26.
15. Li X, Kong X, Huo Q, et al (2011). Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition. Cancer Sci, 102, 1151-7.
16. McBride JL, Boudreau RL, Harper SQ, et al (2008). Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc NatlAcad Sci USA, 105, 5868-73.
17. Nohata N, Hanazawa T, Kikkawa N, et al (2011). Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). JHum Genet, 56, 595-601.
18. Sarkar D, Park ES, Emdad L, et al (2008). Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res, 68, 1478-84
19. SinghS, NarangAS, MahatoRI (2011). Subcellular fate and off-target effects of siRNA, shRNA, and miRNA. Pharm Res, 28, 2996-3015.
20. Song H, Li C, Li R, Geng J (2010). Prognostic significance of AEG-1 expression in colorectal carcinoma. Int J Colorectal Dis, 25, 1201-9.
21. Song H, Li C, Lu R, Zhang Y, Geng J (2010). Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer. Int J Gynecol Cancer, 20, 1188-96.
22. Wang Z, Rao DD, Senzer N, Nemunaitis J (2011). RNA interference and cancer therapy. Pharm Res, 28, 2983-95.
23. Yoo BK, Emdad L, Su ZZ, et al (2009). Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest, 119, 465-77.
24. Zhao Y, Kong X, Li X, et al (2011). Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells. PLoS One, 6, e29363